文献速递生殖医学

优化标准培养卵母细胞受精评估时机:基于78 348枚胚胎的时差成像分析

Optimisation of the timing of fertilisation assessment for oocytes cultured in standard incubation: lessons learnt from time-lapse imaging of 78 348 embryos.
PubMed 文献 · Hum Reprod · 2021-01-01

该回顾性多中心分析利用2011年1月至2019年11月时差成像培养的54 746枚ICSI胚胎和23 602枚IVF胚胎,记录原核出现与消失时间,确定15至20 hpi每30分钟区间内可见双原核的卵母细胞数。结果显示16.5±0.5 hpi为最佳评估时机,现行17±1 hpi共识需修改以减少漏判受精。

要点

  • 16.5±0.5 hpi是标准培养卵母细胞受精评估的最佳时机。
  • 16–16.5 hpi可见原核卵母细胞比例最高(98.32%)。
  • 遵循现行共识可能使超过11%(n=3000)卵母细胞被误判未受精。

核心结论

  • 标准培养卵母细胞受精评估最佳时机为16.5±0.5 hpi,现行共识需修改以减少漏判受精。

研究设计与样本

  • 回顾性多中心分析,纳入2011年1月至2019年11月时差成像培养的54 746枚ICSI胚胎和23 602枚IVF胚胎。
  • 利用时差成像记录原核出现与消失时间,统计15至20 hpi每30分钟区间内可见双原核的卵母细胞数。

主要发现

  • 15至17.5 hpi期间,可见双原核(正常受精)的卵母细胞平均比例为98.19%。
  • 16–16.5 hpi可见原核卵母细胞比例最高,为98.32%。
  • 18–18.5 hpi可见原核比例降至95.53%,19.5–20 hpi进一步降至87.02%。

关键数值与推荐

  • 专家共识推荐受精评估时机为17±1 hpi,本研究建议优化为16.5±0.5 hpi。
  • 无时差成像且遵循现行共识时,本队列中超过11%(n=3000)卵母细胞会被标记为未受精。
  • 根据标准评估时间,多达300枚最终活产的胚胎可能因常规评估时点无可见原核而被判为未受精。

临床怎么用

  • 在标准培养条件下,可考虑将受精评估时间调整至16.5±0.5 hpi以最大化识别受精卵母细胞。
  • 该时机优化有助于增加可移植胚胎数量,但替代培养液或培养环境可能需要重新校准。

局限性

  • IVF来源胚胎无法常规记录原核出现时间,无法确定其最佳受精评估时机。
  • 不同培养液和培养环境可能需重新校准该评估时机。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Using time-lapse data, can the current consensus for the timing of fertilisation assessment of oocytes, cultured in standard incubation, be optimised? SUMMARY ANSWER: The optimum time to perform fertilisation assessment for oocytes cultured in standard incubation is 16.5 ± 0.5 h post-insemination (hpi), and the current consensus requires modification in order to minimise the chance of fertilisation being missed. WHAT IS KNOWN ALREADY: Time-lapse incubation allows the embryologist to retrospectively review collated images of oocytes and embryos to capture important embryological observations that may otherwise be missed in standard incubation. According to expert consensus, the optimum time to perform the assessment of fertilisation is 17 ± 1 hpi. STUDY DESIGN, SIZE, DURATION: A retrospective, multicentre analysis utilised data obtained from 54 746 ICSI-derived embryos and 23 602 IVF-derived embryos cultured in time-lapse incubation between January 2011 and November 2019. PARTICIPANTS/MATERIALS, SETTING, METHODS: Using time-lapse imaging (TLI), the precise time of pronuclei appearance and disappearance was recorded, where applicable, and the number of oocytes with two pronuclei observable during 10 30-min intervals from 15 hpi to 20 hpi was determined. MAIN RESULTS AND THE ROLE OF CHANCE: Between 15 and 17.5 hpi, the average number of oocytes exhibiting normal fertilisation, elicited as two pronuclei, was 98.19% with the highest proportion of oocytes having visible pronuclei at 16-16.5 hpi (98.32%). At 18-18.5 hpi, the number of visible pronuclei reduced to 95.53% and continued to fall to 87.02% at 19.5-20 hpi. LIMITATIONS, REASONS FOR CAUTION: The authors' expectation is that these findings are transferable to other settings, however it is possible that, with alternative culture media and incubation environments, calibration of this timing may be required. As data cannot readily be recorded for pronuclear appearance for IVF-derived embryos, it is not possible to determine the optimum time to perform the fertilisation assessment for IVF-derived embryos. WIDER IMPLICATIONS OF THE FINDINGS: By fine-tuning the time at which fertilisation assessment takes place the accuracy of the assessment can be increased to maximise the number of fertilised oocytes identified, thereby increasing the number of usable embryos for the patient. Without TLI and following current consensus guidelines, over 11% (n = 3000) of oocytes would have been marked as unfertilised within this cohort. Further to this, depending on the time of a standard fertilisation assessment, up to 300 embryos which resulted in live births could have been categorised as unfertilised, as they presented no visible pronuclei at the conventional assessment time-point. STUDY FUNDING/COMPETING INTEREST(S): A.C. is a minor shareholder in CARE Fertility Limited. Validated algorithmic time-lapse embryo selection is offered to patients at CARE Fertility at an additional charge as an adjuvant treatment option. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Barrie A, Smith R, Campbell A, et al. Optimisation of the timing of fertilisation assessment for oocytes cultured in standard incubation: lessons learnt from time-lapse imaging of 78 348 embryos. Hum Reprod. 2021. PMID: 34536006. doi:10.1093/humrep/deab209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。